.png
)
In the pharmaceutical world, Adverse Drug Reactions (ADRs) are not just unfortunate events — they’re regulatory red flags, patient safety threats, and potential business disasters. Why is this so critical? Because a single overlooked ADR can lead to product…
Published on: 16th April, 2025 The Central Drugs Standard Control Organization (CDSCO) has released a crucial directive dated 11th April, 2025, addressing the unauthorized manufacture and marketing of Fixed Dose Combinations (FDCs) by pharmaceutical manufacturers in India. The notification highlights…
Published On: 11th April, 2025 In a decisive move aimed at promoting manufacturing and sale of medical devices for domestic and export market, the Central Drugs Standard Control Organization (CDSCO) has announced a significant upgrade in its online licensing system.…
March 21, 2025 Central Drugs Standard Control Organization, Government of India has been mandated to ensure that the drugs being manufactured and imported into the country meet the standards of quality, safety and efficacy. This has led to the Government…
5th March, 2025 The Ministry of Health and Family Welfare, Government of India, has taken a significant step to streamline and enhance the registration process for Clinical Research Organizations (CRO) by mandating online registration through the SUGAM portal. This initiative,…